Neurology News and Research

Latest Neurology News and Research

Valeant Pharmaceuticals receives Complete Response Letter from FDA for efinaconazole NDA

Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.

28 May 2013

Exposure to bug or weed killers is associated with higher risk of Parkinson's disease

A large analysis of more than 100 studies from around the world shows that exposure to pesticides, or bug and weed killers, and solvents is likely associated with a higher risk of developing Parkinson's disease. The research appears in the May 28, 2013, print issue of Neurology-, the medical journal of the American Academy of Neurology.

28 May 2013

New AAN guideline provides direction for use of blood thinners during surgery

A new guideline from the American Academy of Neurology will help people who take blood thinners decide whether or not to take them during surgery or other medical procedures.

28 May 2013

New Translational Proteomics journal launched by Elsevier

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Translational Proteomics, an online-only, open access journal devoted to transferring fundamental discoveries in the field of proteomics to clinical applications, accelerating understanding and treatment of human diseases.

28 May 2013

Boston Scientific's GUIDE DBS System gets CE Mark approval

Boston Scientific Corporation has received CE Mark approval for use of the GUIDE DBS System, the world's first deep brain stimulation visualization system.

28 May 2013

Study could open up new possibilities for early diagnosis of motor disorders

The scientists report these findings in the current online edition of "The Lancet Neurology". This pan-European study could open up new possibilities of early diagnosis and smooth the way for treatments which tackle diseases before the patient's nervous system is irreparably damaged.

24 May 2013

The Berman Brain & Spine Institute at LifeBridge Health is acknowledged for excellence in stroke care

The Sandra and Malcolm Berman Brain & Spine Institute at LifeBridge Health has been acknowledged for the exceptional quality of its stroke care with a Target: Stroke designation and two Get With The Guidelines®-Stroke Gold Plus Quality Achievement Awards from the American Heart Association/American Stroke Association.

24 May 2013

New study determines that children with temporal lobe epilepsy likely to have depression

A new study determined that children and adolescents with seizures involving the temporal lobe are likely to have clinically significant behavioral problems and psychiatric illness, especially depression.

24 May 2013

Heart disease signs in newborns: an interview with Dr Michael Skilton, University of Sydney

Thickening of the walls of the main arteries is the best indicator of poor cardiovascular health in healthy young children.

23 May 2013

American Heart Association: Costs to treat stroke may increase to $183.13 billion in 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

23 May 2013

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Cognoptix, an emerging medical device company, announced today that its SAPPHIRE II eye test identified Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes in a 10-subject proof-of-concept clinical trial.

23 May 2013

$Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS$

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology.

23 May 2013

Multiple studies examine ideal biomarkers for Huntington's disease

While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may eventually be used as outcome measures in clinical trials. Biomarkers could be especially helpful to monitor changes during the time prior to diagnosis and appearance of overt symptomatology.

21 May 2013

Men diagnosed with ADHD in childhood are at higher risk to suffer from obesity as adults: Study

A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder were twice as likely to be obese in a 33-year follow-up study compared to men who were not diagnosed with the condition.

21 May 2013

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration for the treatment of major depressive disorder.

20 May 2013

Television actor hosts latest free patient education DVD and guidebook on epilepsy

Television actor and "Dancing with the Stars" winner John O'Hurley is the host of Epilepsy: A Guide for Patients and Families, the latest free patient education DVD and guidebook produced by the American Academy of Neurology and its foundation, the American Brain Foundation.

20 May 2013

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

UCB today announced data from a double-blind, placebo-controlled study that found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure elevations associated with periodic limb movements during sleep and total PLMS in patients with idiopathic moderate-to-severe Restless Legs Syndrome/Willis-Ekbom disease.

18 May 2013

Loss of Merlin protein leads to abnormal growth of tumours

A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.

17 May 2013

Metal-on-metal hip implants cause inflammation of joint lining long before symptoms appear

Metal-on-metal hip implants can cause inflammation of the joint lining (synovitis) long before symptoms appear, and magnetic resonance imaging (MRI) can be used to identify this inflammation, according to a new study by researchers at Hospital for Special Surgery. The study, which appears in an upcoming issue of the Journal of Bone & Joint Surgery, demonstrates that MRI can be used to identify implants that are going to fail before people become symptomatic.

17 May 2013

Research: People with skin cancer may be less likely to develop Alzheimer's disease

People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The link does not apply to melanoma, a less common but more aggressive type of skin cancer.

17 May 2013

Neurology News and Research

Latest Neurology News and Research

Valeant Pharmaceuticals receives Complete Response Letter from FDA for efinaconazole NDA

Exposure to bug or weed killers is associated with higher risk of Parkinson's disease

New AAN guideline provides direction for use of blood thinners during surgery

New Translational Proteomics journal launched by Elsevier

Boston Scientific's GUIDE DBS System gets CE Mark approval

Study could open up new possibilities for early diagnosis of motor disorders

The Berman Brain & Spine Institute at LifeBridge Health is acknowledged for excellence in stroke care

New study determines that children with temporal lobe epilepsy likely to have depression

Heart disease signs in newborns: an interview with Dr Michael Skilton, University of Sydney

American Heart Association: Costs to treat stroke may increase to $183.13 billion in 2030

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Multiple studies examine ideal biomarkers for Huntington's disease

Men diagnosed with ADHD in childhood are at higher risk to suffer from obesity as adults: Study

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Television actor hosts latest free patient education DVD and guidebook on epilepsy

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

Loss of Merlin protein leads to abnormal growth of tumours

Metal-on-metal hip implants cause inflammation of joint lining long before symptoms appear

Research: People with skin cancer may be less likely to develop Alzheimer's disease

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Neurology News and Research

Latest Neurology News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in